Last reviewed · How we verify
NCT05025111
Entia Liberty: Capillary Validation
trial testing Entia Liberty in Cancer in 150 participants. Completed in 26 October 2022.
26 October 2022
Quick facts
| Lead sponsor | Entia Ltd |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 12 September 2022 |
| Primary completion | 26 October 2022 |
| Estimated completion | 26 October 2022 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Entia Liberty
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
Entia Ltd
Who can join
18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a clinical performance validation study to evaluate the performance of the Entia Liberty device. Patients undergoing routine venepuncture blood tests will be recruited to have an Entia Liberty test (by finger-prick) done on them by a trained healthcare professional. The results from that finger-prick test will be compared against the results from the routine venepuncture blood test (reference method) and subsequently, excess blood from the routine venepuncture test will be run on another Entia Liberty device in the laboratory. All three results (Entia Liberty capillary, Entia Liberty venous and gold standard venous) will be compared against each other to prove Entia Liberty's performance claims.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05025111
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Entia Liberty
Trials testing the same drug.
- NCT06134245 — HOme USability Evaluation · unknown
- NCT05462288 — Entia Liberty: Home Study · completed
- NCT05025124 — Entia Liberty: Accuracy and Precision · completed
- NCT05027256 — Entia Liberty: Usability Validation · completed
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Entia Ltd trials
Trials by the same sponsor.
- NCT07031882 — Liberty Analyzer WBC System: Reference Interval Study · not yet recruiting
- NCT06544070 — Capillary Blood Accuracy · not yet recruiting
- NCT06134245 — HOme USability Evaluation · unknown
- NCT05926362 — Capillary-Venous Paired Data Collection · not yet recruiting
- NCT05462288 — Entia Liberty: Home Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05025111 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Entia Ltd
- Last refreshed: 27 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05025111.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing